1,214
Views
32
CrossRef citations to date
0
Altmetric
Drug Evaluation

Abatacept for the treatment of systemic lupus erythematosus

, &
Pages 493-499 | Received 05 Oct 2015, Accepted 12 Feb 2016, Published online: 07 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ana Neves, Luísa Viveiros, Veronica Venturelli & David A Isenberg. (2023) Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities. Research and Reports in Urology 15, pages 333-353.
Read now
Milena Tocut, Yehuda Shoenfeld & Gisele Zandman-Goddard. (2020) Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development. Expert Opinion on Investigational Drugs 29:10, pages 1151-1162.
Read now
Wilma Barcellini, Bruno Fattizzo & Anna Zaninoni. (2019) Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. Journal of Blood Medicine 10, pages 265-278.
Read now

Articles from other publishers (29)

Xiuzhi Jia, Yuewen Lu, Xunhua Zheng, Ruihan Tang & Wei Chen. (2023) Targeted therapies for lupus nephritis: Current perspectives and future directions. Chinese Medical Journal.
Crossref
Juan Camilo Santacruz, Marta Juliana Mantilla, Sandra Pulido, Juan Ramón Isaza, Eduardo Tuta, Carlos Alberto Agudelo & John Londono. (2023) A Practical Overview of the Articular Manifestations of Systemic Lupus Erythematosus. Cureus.
Crossref
Yibing Han, Lingwei Liu, Bo Zang, Ruiwen Liang, Xinyue Zhao & Bin Liu. (2023) Advances in natural products and antibody drugs for SLE: new therapeutic ideas. Frontiers in Pharmacology 14.
Crossref
Fulvia Ceccarelli, Marcello Govoni, Matteo Piga, Giulia Cassone, Francesco Paolo Cantatore, Giulio Olivieri, Alberto Cauli, Ennio Giulio Favalli, Fabiola Atzeni, Elisa Gremese, Florenzo Iannone, Roberto Caporali, Marco Sebastiani, Gian Franco Ferraccioli, Giovanni Lapadula & Fabrizio Conti. (2022) Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium. Journal of Clinical Medicine 11:20, pages 6016.
Crossref
Anna Radziszewska, Zachary Moulder, Elizabeth C. Jury & Coziana Ciurtin. (2022) CD8+ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease. International Journal of Molecular Sciences 23:19, pages 11431.
Crossref
E. L. Nasonov, S. K. Soloviev & A. V. Arshinov. (2022) Systemic lupus erythematosus: history and modernity. Rheumatology Science and Practice 60:4, pages 397-412.
Crossref
Agner R. Parra Sánchez, Alexandre E. Voskuyl & Ronald F. van Vollenhoven. (2022) Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nature Reviews Rheumatology 18:3, pages 146-157.
Crossref
Ana-Luisa Stefanski & Thomas Dörner. (2021) Immune checkpoints and the multiple faces of B cells in systemic lupus erythematosus. Current Opinion in Rheumatology 33:6, pages 592-597.
Crossref
Zoltán Szekanecz, Iain B. McInnes, Georg Schett, Szilvia Szamosi, Szilvia Benkő & Gabriella Szűcs. (2021) Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nature Reviews Rheumatology 17:10, pages 585-595.
Crossref
Stinne Ravn Greisen & Bent Deleuran. (2021) Checkpoint Molecules in Rheumatology—or the Benefits of Being Exhausted. Current Rheumatology Reports 23:4.
Crossref
Zheng Xu, Chun-Chieh Lin, Sophey Ho, George Vlad & Nicole Suciu-Foca. (2021) Suppression of Experimental Autoimmune Encephalomyelitis by ILT3.Fc. The Journal of Immunology 206:3, pages 554-565.
Crossref
Antonio La Cava. 2021. Lahita's Systemic Lupus Erythematosus. Lahita's Systemic Lupus Erythematosus 81 98 .
Zhi-Hui Xiong, Xiao-Song Cao, Hai-Lian Guan & Hui-Ling Zheng. (2020) Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature. World Journal of Clinical Cases 8:24, pages 6396-6407.
Crossref
Javier Narváez. (2020) Lupus eritematoso sistémico 2020. Medicina Clínica 155:11, pages 494-501.
Crossref
Javier Narváez. (2020) Lupus erythematosus 2020. Medicina Clínica (English Edition) 155:11, pages 494-501.
Crossref
Stephanie Grebinoski & Dario AA Vignali. (2020) Inhibitory receptor agonists: the future of autoimmune disease therapeutics?. Current Opinion in Immunology 67, pages 1-9.
Crossref
Daniella Muallem Schwartz, Aarohan M. Burma, Moses M. Kitakule, Yiming Luo & Nehal N. Mehta. (2020) T Cells in Autoimmunity-Associated Cardiovascular Diseases. Frontiers in Immunology 11.
Crossref
Bingyi Yang, Ming Zhao, Haijing Wu & Qianjin Lu. (2020) A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target. Frontiers in Immunology 11.
Crossref
I-Ping Lee, Han-Bin Boey, Sheng-Hong Lin & Yu-Sheng Chang. (2020) Severe systemic lupus erythematosus flare after abatacept treatment. Lupus 29:12, pages 1650-1651.
Crossref
Masayuki Mizui & George C. Tsokos. 2020. The Autoimmune Diseases. The Autoimmune Diseases 533 551 .
Sultan M. Almogairen. (2019) Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in mice. BMC Pharmacology and Toxicology 20:1.
Crossref
Irene Carrión-Barberà, Melissa Fajardo, George Danias, Demetra Tsapepas, Yevgeniya Gartshteyn, Hilda Fernandez & Anca Askanase. (2019) Belatacept in kidney transplant patients with systemic lupus erythematosus. Lupus Science & Medicine 6:1, pages e000355.
Crossref
Manqing Wu & Jun Shen. (2019) From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions. Frontiers in Oncology 9.
Crossref
Fuhua Lu, Maoshu Zhu, Ying Lin, Hongbin Zhong, Lei Cai, Lin He & Kuo-Chen Chou. (2019) The preliminary efficacy evaluation of the CTLA-4-Ig treatment against Lupus nephritis through in-silico analyses. Journal of Theoretical Biology 471, pages 74-81.
Crossref
Antonio Julià, Francisco Javier López-Longo, José J. Pérez Venegas, Silvia Bonàs-Guarch, Àlex Olivé, José Luís Andreu, Mª. Ángeles Aguirre-Zamorano, Paloma Vela, Joan M. Nolla, José Luís Marenco de la Fuente, Antonio Zea, José María Pego-Reigosa, Mercedes Freire, Elvira Díez, Esther Rodríguez-Almaraz, Patricia Carreira, Ricardo Blanco, Víctor Martínez Taboada, María López-Lasanta, Mireia López Corbeto, Josep M. Mercader, David Torrents, Devin Absher, Sara Marsal & Antonio Fernández-Nebro. (2018) Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Research & Therapy 20:1.
Crossref
F Speth, C H Hinze, P Schranz, E Miller-Wiegart & R Haefner. (2018) Combination of rituximab and abatacept as an exit strategy for repetitive B-cell depletion in children with severe autoimmune diseases: a report of three cases. Lupus 27:12, pages 1996-1998.
Crossref
Jennifer Hess, Leon Su, Frank Nizzi, Kristen Beebe, Kyrie Magee, Dana Salzberg, Jennifer Stahlecker, Holly K. Miller, Roberta H. Adams & Alexander Ngwube. (2018) Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept. Transfusion 58:9, pages 2122-2127.
Crossref
Jay Mehta & Timothy Beukelman. (2017) Biologic Agents in the Treatment of Childhood-Onset Rheumatic Disease. The Journal of Pediatrics 189, pages 31-39.
Crossref
Laurie S. Davis & Andreas M. Reimold. (2017) Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus. Rheumatology 56:suppl_1, pages i100-i113.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.